Senores Pharmaceuticals Ltd.

•

senorespharma.comBSE: 544319NSE: SENORES

Market Cap₹ 6,758 Cr.

Current Price

High / Low₹ 1,599 / 662

Stock P/E53.5

Book Value₹ 209

Price to Book3.74

Dividend Yield0.00 %

ROCE15.7 %

ROE14.1 %

Face Value₹ 10

Add ratio to table

ABOUT

AI Sector View

AI GENERATED

Healthcare

Buy

This stance relies on proxies and positioning because no direct pharma-export or healthcare operating series exists in the dataset. The depreciated currency at 95.23 (Sep/26) can support export earnings, inflation at 4.45% (Jul/26) is manageable for a defensive sector, and consumer spending remains large at INR 44743 billion (Jun/26). Strong FPI inflow of INR 10620 crore over 3 months to 2026-08-31 from INR -11381 crore in the prior 3 months adds a real sector-specific tailwind, but confidence stays capped because the fundamental drivers are indirect proxies.

Confidence

50%

View full sector analysis →

PROS

Latest quarter profit grew 43.8% YoY, showing strong momentum
Company has consistently been profitable over the last 5 years
Working capital cycle has improved - days down from 442 to 224
Company comfortably covers its interest (7.4x coverage)
Institutional investors have been accumulating - FII+DII up 3.2pp
Attractively priced for its growth - PEG of 0.4

CONS

Receivables are growing faster than sales - a possible quality concern
A large part of profit comes from other income (29.6% of PBT)
Poor cash conversion - profits are not backed by operating cash flow (CFO/PAT -0.05x)
Operating cash flow has been negative in recent years
Equity base is being diluted - shares outstanding up 369.2%
Free cash flow has been persistently negative

* The pros and cons are machine generated based on quantitative rules.

Peer comparison

HealthcareHealthcarePharmaceuticals & Drugs

Part ofNIFTY 50 NIFTY 500 NIFTY LARGEMIDCAP 250 NIFTY 100 NIFTY 200

S.No.	Name
1.	SUNPHARMA	1842.00	36.54	441957.50	0.87	2901.23	26.53	15299.88	10.98	19.11	28.81
2.	DIVISLAB	9326.00	84.64	247576.00	0.32	902.00	65.50	3080.00	27.80	21.51	40.75
3.	TORNTPHARM	4975.00	86.76	189233.01	0.76	566.00	3.28	4921.00	57.32	19.27	33.81
4.	ZYDUSLIFE	1119.50	24.74	111670.55	0.09	990.20	-34.90	8017.00	23.97	21.39	24.54
5.	CIPLA	1365.00	32.72	110272.68	0.95	785.55	-39.18	7119.28	4.13	16.00	16.73
6.	LAURUSLABS	1970.35	97.37	106460.42	0.10	362.07	123.94	2026.31	29.10	18.20	31.50
7.	DRREDDY	1161.00	30.07	96906.38	0.69	435.60	-69.10	8099.80	-5.21	13.75	10.63
8.	AUROPHARMA	1675.45	25.97	96401.69	0.24	1032.03	25.22	9150.35	17.44	12.76	20.54
9.	LUPIN	2096.00	17.34	95842.92	0.86	1416.98	16.01	8276.89	34.28	28.86	29.59
10.	MANKIND	2277.00	46.04	94050.37	0.04	574.09	29.12	4030.59	12.89	13.24	26.30
11.	GLENMARK	2416.90	37.94	68210.88	0.10	482.83	927.88	4018.48	31.35	20.35	20.03
12.	SENORES	1467.45	53.48	6758.13	0.00	30.45	43.77	180.21	38.30	15.66	29.83

Detailed Comparison with:

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	79	102	80	98	103	114	130	153	165	175	180
	64	80	59	77	77	95	104	112	121	128	144
Operating Profit	15	22	20	21	26	19	26	41	44	47	37
OPM %	19.25%	21.86%	25.70%	21.25%	24.93%	17.02%	20.31%	26.81%	26.87%	27.11%	20.34%
	1	2	0	2	5	12	3	5	4	18	3
Interest	2	3	5	5	6	5	5	6	5	8	7
Depreciation	3	4	4	4	4	5	6	8	8	9	10
Profit before Tax	10	18	13	16	20	21	26	41	45	47	39
Tax %	30.63%	19.48%	18.95%	18.24%	19.82%	13.10%	20.05%	25.89%	24.69%	22.64%	22.83%
Net Profit	0	0	0	0	16	18	21	30	34	37	30
	4.01	8.03	3.39	3.92	5.04	3.81	4.60	6.54	7.29	7.96	6.61

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
	14	35	215	398	633	674
	12	23	173	309	464	504
Operating Profit	2	13	42	90	168	170
OPM %	13.78%	35.85%	19.38%	22.52%	26.61%	25.17%
	0	4	3	19	47	30
Interest	1	2	9	22	25	27
Depreciation	1	2	10	17	31	35
Profit before Tax	1	12	25	71	159	172
Tax %	13.30%	32.19%	-31.15%	17.33%	23.61%	23.98%
Net Profit	1	8	33	58	122	131
EPS	1.81	6.65	10.31	12.72	25.05	—
Dividend Payout %	0.00%	0.00%	0.00%	0.00%	0.00%	—

COMPOUNDED SALES GROWTH

10 Years:: —
5 Years:: —
3 Years:: 162%

COMPOUNDED PROFIT GROWTH

10 Years:: —
5 Years:: —
3 Years:: 139%

STOCK PRICE CAGR

10 Years:: —
5 Years:: —
3 Years:: —
1 Year:: 107%

RETURN ON EQUITY

10 Years:: —
5 Years:: 15%
3 Years:: 17%
Last Year:: 14%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	9	10	31	46	46
Minority Interest	0	0	27	26	31
	28	36	174	740	887
	15	59	238	293	327
Trade Payables	7	14	113	67	235
	0	12	24	36	77
Total Liabilities	59	131	607	1,208	1,604
	7	27	235	301	499
Capital Work in Progress	0	8	18	44	17
	15	16	0	0	4
	3	3	37	57	89
	0	0	112	124	325
Cash & Bank	3	0	13	386	160
	30	76	191	297	510
Total Assets	59	131	607	1,208	1,604

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	-10	0	-26	-46	62
Cash from Investing	-24	-48	-54	-429	-121
Cash from Financing	36	46	87	573	-1
	2	-3	7	98	-60

Ratios

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026

Shareholding Pattern

Numbers in percentages

	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	45.76	45.76	45.77	45.78	45.80	45.80	45.82	45.82
	5.52	4.24	4.17	3.66	4.28	3.35	3.64	6.62
	16.61	11.49	9.66	9.51	8.62	9.32	9.62	9.77
Government	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
	32.11	38.48	40.40	41.04	41.31	41.54	40.93	37.79

Documents

Corporate disclosures, annual reports, credit ratings, and concall transcripts

2026-09-11

General Updates

2026-09-11 - Senores Pharmaceuticals Limited has informed the Exchange about Successful Completion of USFDA Inspection

2026-09-04

Copy of Newspaper Publication

2026-09-04 - Senores Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper Publication with respect to the 9th Annual General Meeting of the Company.

2026-09-03

Shareholders meeting

2026-09-03 - Senores Pharmaceuticals Limited has informed the Exchange regarding Notice of 9th Annual General Meeting to be held on September 25, 2026

2026-08-27

Analysts/Institutional Investor Meet/Con. Call Updates

2026-08-27 - Senores Pharmaceuticals Limited has informed the Exchange about Schedule of meet

2026-08-27

Copy of Newspaper Publication

2026-08-27 - Senores Pharmaceuticals Limited has informed the Exchange regarding copy of newspaper publication for pre dispatch of Annual Report for the forthcoming Annual General Meeting of the Company

2026-08-26

Appointment

2026-08-26 - Senores Pharmaceuticals Limited has informed the Exchange regarding Appointment of Mr Viranchi Arvindbhai Shah as Non- Executive Independent Director of the company w.e.f. August 26, 2026.

2026-08-26

General Updates

2026-08-26 - Approval of Senores Pharmaceuticals Employee Stock Option Scheme 2026 ( ESOS 2026 / SCHEME )

2026-08-26

General Updates

2026-08-26 - Proposed incorporation of a Wholly Owned Subsidiary (WOS) in Mexico

2026-08-26

General Updates

2026-08-26 - Proposed incorporation of a Subsidiary Company in Canada

News

Recent coverage and analyst commentary for SENORES

Loading news…

🤖

AI Stock Analyst

Senores Pharmaceuticals Ltd.

🔒

Sign in to Chat with AI

✨ Sign In to Chat

Free 5nance Account

Name

SUNPHARMA

1842.00

36.54

441957.50

0.87

2901.23

26.53

15299.88

10.98

19.11

28.81

DIVISLAB

9326.00

84.64

247576.00

0.32

902.00

65.50

3080.00

27.80

21.51

40.75

TORNTPHARM

4975.00

86.76

189233.01

0.76

566.00

3.28

4921.00

57.32

19.27

33.81

ZYDUSLIFE

1119.50

24.74

111670.55

0.09

990.20

-34.90

8017.00

23.97

21.39

24.54

CIPLA

1365.00

32.72

110272.68

0.95

785.55

-39.18

7119.28

4.13

16.00

16.73

LAURUSLABS

1970.35

97.37

106460.42

0.10

362.07

123.94

2026.31

29.10

18.20

31.50

DRREDDY

1161.00

30.07

96906.38

0.69

435.60

-69.10

8099.80

-5.21

13.75

10.63

AUROPHARMA

1675.45

25.97

96401.69

0.24

1032.03

25.22

9150.35

17.44

12.76

20.54

LUPIN

2096.00

17.34

95842.92

0.86

1416.98

16.01

8276.89

34.28

28.86

29.59

MANKIND

2277.00

46.04

94050.37

0.04

574.09

29.12

4030.59

12.89

13.24

26.30

GLENMARK

2416.90

37.94

68210.88

0.10

482.83

927.88

4018.48

31.35

20.35

20.03

SENORES

1467.45

53.48

6758.13

0.00

30.45

43.77

180.21

38.30

15.66

29.83

Dec 2023

Mar 2024

Jun 2024

Sep 2024

Dec 2024

Mar 2025

Jun 2025

Sep 2025

Dec 2025

Mar 2026

Jun 2026

102

103

114

130

153

165

175

180

104

112

121

128

144

Operating Profit

OPM %

19.25%

21.86%

25.70%

21.25%

24.93%

17.02%

20.31%

26.81%

26.87%

27.11%

20.34%

Interest

Depreciation

Profit before Tax

Tax %

30.63%

19.48%

18.95%

18.24%

19.82%

13.10%

20.05%

25.89%

24.69%

22.64%

22.83%

Net Profit

4.01

8.03

3.39

3.92

5.04

3.81

4.60

6.54

7.29

7.96

6.61

Mar 2022

Mar 2023

Mar 2024

Mar 2025

Mar 2026

TTM

215

398

633

674

173

309

464

504

Operating Profit

168

170

OPM %

13.78%

35.85%

19.38%

22.52%

26.61%

25.17%

Interest

Depreciation

Profit before Tax

159

172

Tax %

13.30%

32.19%

-31.15%

17.33%

23.61%

23.98%

Net Profit

122

131

EPS

1.81

6.65

10.31

12.72

25.05

—

Dividend Payout %

0.00%

—

Mar 2022

Mar 2023

Mar 2024

Mar 2025

Mar 2026

Equity Capital

Minority Interest

174

740

887

238

293

327

Trade Payables

113

235

Total Liabilities

131

607

1,208

1,604

235

301

499

Capital Work in Progress

112

124

325

Cash & Bank

386

160

191

297

510

Total Assets

131

607

1,208

1,604

Mar 2022

Mar 2023

Mar 2024

Mar 2025

Mar 2026

-10

-26

-46

Cash from Investing

-24

-48

-54

-429

-121

Cash from Financing

573

-1

-3

-60

Mar 2022

Mar 2023

Mar 2024

Mar 2025

Mar 2026

Sep 2024

Dec 2024

Mar 2025

Jun 2025

Sep 2025

Dec 2025

Mar 2026

Jun 2026

45.76

45.77

45.78

45.80

45.82

5.52

4.24

4.17

3.66

4.28

3.35

3.64

6.62

16.61

11.49

9.66

9.51

8.62

9.32

9.62

9.77

Government

0.00

32.11

38.48

40.40

41.04

41.31

41.54

40.93

37.79

Senores Pharmaceuticals Ltd.

AI Sector View

Peer comparison

Quarterly Results

Profit & Loss

Balance Sheet

Corporate actions

Cash Flows

Ratios

Shareholding Pattern

Documents

News

Sign in to Chat with AI

Senores Pharmaceuticals Ltd.

AI Sector View

Peer comparison

Quarterly Results

Profit & Loss

Balance Sheet

Corporate actions

Cash Flows

Ratios

Shareholding Pattern

Documents

News

Sign in to Chat with AI